How are TLRY strangle max profit and max loss calculated?

Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the TLRY strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 73.66%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$62.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.

What is the breakeven for a TLRY strangle?

The breakeven for the TLRY strangle priced on this page is roughly $4.38 and $6.12 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current TLRY market-implied 1-standard-deviation expected move is approximately 21.12%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.

How does current TLRY implied volatility affect this strangle?

TLRY ATM IV is at 73.66% with IV rank near 0.00%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

TLRY Strangle Strategy

TLRY (Tilray Brands, Inc.), in the Healthcare sector, (Drug Manufacturers - Specialty & Generic industry), listed on NASDAQ.

Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils, vapes, edibles, and topicals; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, P'tite Pof, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc.

TLRY (Tilray Brands, Inc.) trades in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a market capitalization of approximately $653.0M, a beta of 1.94 versus the broader market, a 52-week range of 3.5-23.2, average daily share volume of 4.5M, a public-listing history dating back to 2018, approximately 3K full-time employees. These structural characteristics shape how TLRY stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 1.94 indicates TLRY has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.

What is a strangle on TLRY?

A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.

Current TLRY snapshot

As of May 15, 2026, spot at $5.30, ATM IV 73.66%, IV rank 0.00%, expected move 21.12%. The strangle on TLRY below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 28-day expiry.

Why this strangle structure on TLRY specifically: TLRY IV at 73.66% is on the cheap side of its 1-year range, which favors premium-buying structures like a TLRY strangle, with a market-implied 1-standard-deviation move of approximately 21.12% (roughly $1.12 on the underlying). The 28-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated TLRY expiries trade a higher absolute premium for lower per-day decay. Position sizing on TLRY should anchor to the underlying notional of $5.30 per share and to the trader's directional view on TLRY stock.

TLRY strangle setup

The TLRY strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With TLRY near $5.30, the first option leg uses a $5.50 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed TLRY chain at a 28-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 TLRY shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Buy 1	Call	$5.50	$0.34
Buy 1	Put	$5.00	$0.28

TLRY strangle risk and reward

Net Premium / Debit: -$62.00
Max Profit (per contract): Unbounded
Max Loss (per contract): -$62.00
Breakeven(s): $4.38, $6.12
Risk / Reward Ratio: Unbounded

Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.

TLRY strangle payoff curve

Modeled P&L at expiration across a range of underlying prices for the strangle on TLRY. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

Underlying Price	% From Spot	P&L at Expiration
$0.01	-99.8%	+$437.00
$1.18	-77.7%	+$319.92
$2.35	-55.6%	+$202.85
$3.52	-33.5%	+$85.77
$4.69	-11.5%	-$31.30
$5.86	+10.6%	-$25.62
$7.03	+32.7%	+$91.45
$8.21	+54.8%	+$208.53
$9.38	+76.9%	+$325.60
$10.55	+99.0%	+$442.68

When traders use strangle on TLRY

Strangles on TLRY are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the TLRY chain.

TLRY thesis for this strangle

The market-implied 1-standard-deviation range for TLRY extends from approximately $4.18 on the downside to $6.42 on the upside. A TLRY long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current TLRY IV rank near 0.00% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on TLRY at 73.66%. As a Healthcare name, TLRY options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to TLRY-specific events.

TLRY strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. TLRY positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move TLRY alongside the broader basket even when TLRY-specific fundamentals are unchanged. Always rebuild the position from current TLRY chain quotes before placing a trade.

Frequently asked questions

What is a strangle on TLRY?: A strangle on TLRY is the strangle strategy applied to TLRY (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With TLRY stock trading near $5.30, the strikes shown on this page are snapped to the nearest listed TLRY chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are TLRY strangle max profit and max loss calculated?: Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the TLRY strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 73.66%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$62.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a TLRY strangle?: The breakeven for the TLRY strangle priced on this page is roughly $4.38 and $6.12 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current TLRY market-implied 1-standard-deviation expected move is approximately 21.12%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a strangle on TLRY?: Strangles on TLRY are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the TLRY chain.
How does current TLRY implied volatility affect this strangle?: TLRY ATM IV is at 73.66% with IV rank near 0.00%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.